© Sage Journals, The
Author(s)2020
World Journal for
Pediatric and Congenital Heart Surgery (2021) vol 12(2):168-172
DOI 10.1177/2150135120969388
Received: 16 July 2020 /
Accepted: 8 October 2020
Fontan-Associated Anatomical Variants
and Hepatic Fibrosis
Authors
William N Evans,
MD, Ruben J Acherman, MD, Gary A Mayman, MD, Alvaro
Galindo, MD, Abraham Rothman, MD, Michael L Ciccolo, MD, Juan Lehoux, MD, Brody
J Winn, MD, Noel S Yumiaco, MD, Humberto Restrepo,
MD, MPH
Source
Children’s Heart
Center Nevada, 3006 S Maryland Parkway, Ste 690, Las Vegas, NV 89109, USA. Email:
WNevans50@aol.com.
Abstract
Objective:
We hypothesized
that a relationship between post-Fontan hepatic fibrosis and anatomical
variants might exist.
Methods:
Attempting to
limit confounding variables, we analyzed data from living, stable, post-extracardiac Fontan patients who underwent cardiac
catheterization and transvenous hepatic biopsy
procedures between March 2012 and June 2020.
Results:
We identified 120
patients who met the inclusion criteria. Of the 120, 35 (29%) had pulmonary
artery stents. For the 35 with pulmonary artery stents, the average total
fibrosis score was 3.2 ± 1.9 and the fibrosis progression rate was 0.36 ± 0.33,
and for those with no pulmonary artery stents, the total fibrosis score was 2.6
± 1.8 and the fibrosis progression rate was 0.27 ± 0.33 (P = .13 and P = .11,
respectively). Of the 120, 65 had functional univentricles
of right ventricular type. Of these 65, 27 had pulmonary artery stents. For the
27 with pulmonary artery stents, the average total fibrosis score was 3.4 ± 1.8
and the average fibrosis progression rate was 0.39 ± 0.30, and for the 38
without pulmonary artery stents, the average fibrosis score was 2.3 ± 1.5 and
the average fibrosis progression rate was 0.23 ± 0.21 (P = .01 for comparison
of both values).
Conclusions:
This study’s
findings suggest that a post-extracardiac Fontan with
a functional univentricle of right ventricular type
plus a pulmonary artery stent may have more advanced liver pathology than those without a pulmonary artery stent at similar
Fontan duration years and ages at liver biopsy.